Status:
UNKNOWN
Correlation Between COMT Val158Met Polymorphism and Dopaminergic Transporter Density (DAT) in Obese Women
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Obesity
Eligibility:
FEMALE
20-40 years
Brief Summary
The present study aims to evaluate the correlation between the presence of COMT Val158Met polymorphism and the density of dopaminergic transporters (DAT) in young obese women.
Detailed Description
The prevalence of obesity remains increasingly alarming in Brazil and worldwide. The most widely recommended therapy for obesity is lifestyle modification, however, implementing these changes that can...
Eligibility Criteria
Inclusion
- Women with obesity (BMI 30-35kg/m2), with and without COMT Val158Met polymorphism.
Exclusion
- pregnancy
- any active psychiatric or neurological condition at the time of joining the study
- any other significant medical condition
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04815122
Start Date
April 1 2021
End Date
November 1 2021
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Hospital of Ribeirão Preto Medical School
Ribeirão Preto, São Paulo, Brazil, 14048-900